Clinical Trial Update: Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a PD-1 antibody in combination with neoadjuvant chemotherapy for locally advanced cervical cancer is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Uterine Cervical Neoplasm, Uterine Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING